Cargando…

Humoral Response to SARS-CoV-2 in Hemodialysis Patients

Detalles Bibliográficos
Autor principal:	Steers, Nicholas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187745/ https://www.ncbi.nlm.nih.gov/pubmed/34124415 http://dx.doi.org/10.1016/j.ekir.2021.05.036

Ejemplares similares

Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination
por: Zhao, Wen-Man, et al.
Publicado: (2022)

Humoral response to vaccination against SARS-CoV-2 in patients undergoing maintenance hemodialysis
por: Delgado Ureña, Ana, et al.
Publicado: (2023)

The Humoral Response to SARS-CoV-2 Vaccine in Hemodialysis Patients Is Correlated with Nutritional Status
por: Jacobson-Naftali, Merav, et al.
Publicado: (2023)

Significant reduction of humoral response to SARS-CoV-2 4 months after the diagnosis of COVID-19
por: Zhang, Kang, et al.
Publicado: (2020)

Longevity and Clinical Effectiveness of the Humoral and Cellular Responses to SARS-CoV-2 Vaccination in Hemodialysis Patients
por: De Vriese, An S., et al.
Publicado: (2022)

Humoral Immune Response to BBV152 (Covaxin) SARS-CoV-2 Vaccine in Patients on Hemodialysis
por: Vijayaraghavan, Radha, et al.
Publicado: (2023)

SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population
por: Anft, Moritz, et al.
Publicado: (2021)

The Waxing, Waning, and Predictors of Humoral Responses to Vector-Based SARS-CoV-2 Vaccine in Hemodialysis Patients
por: Fu, Chung-Ming, et al.
Publicado: (2022)

SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients
por: Kwiatkowska, Ewa, et al.
Publicado: (2022)

Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2021)

Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients
por: Melin, Jan, et al.
Publicado: (2021)

Humoral Immune Response to SARS-CoV-2 in Iceland
por: Gudbjartsson, Daniel F., et al.
Publicado: (2020)

Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature
por: Notarte, Kin Israel, et al.
Publicado: (2023)

Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis
por: Martin, Paul, et al.
Publicado: (2021)

T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
por: Bsteh, Gabriel, et al.
Publicado: (2021)

Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients
por: Wand, Ori, et al.
Publicado: (2022)

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
por: Mohanraj, Dinesh, et al.
Publicado: (2022)

Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients
por: Oreja-Guevara, Celia, et al.
Publicado: (2022)

Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination
por: van Dam, Koos P. J., et al.
Publicado: (2022)

Humoral Responses and Serological Assays in SARS-CoV-2 Infections
por: Galipeau, Yannick, et al.
Publicado: (2020)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
por: Broseta, José Jesús, et al.
Publicado: (2021)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Antigenic imprinting in SARS‐CoV‐2
por: Reincke, S. Momsen, et al.
Publicado: (2022)

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
por: Bitzenhofer, Michaela, et al.
Publicado: (2022)

Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination
por: Gumber, Leher, et al.
Publicado: (2022)

Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients
por: Mohn, Kristin G.-I., et al.
Publicado: (2022)

Acute exercise and immune response in previously SARS CoV-2 infection
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
por: Ingraham, Nicholas E., et al.
Publicado: (2021)

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
por: Prendecki, Maria, et al.
Publicado: (2021)

Humoral response to SARS‐CoV‐2 and seasonal coronaviruses in COVID‐19 patients
por: Adams, Ortwin, et al.
Publicado: (2021)

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone
por: Cheng, Chongsheng, et al.
Publicado: (2022)

Humoral response to vaccination against SARS-CoV-2 in patients undergoing dialysis
por: Lee, Yoo Jin, et al.
Publicado: (2022)

Humoral Response after SARS-CoV-2 Vaccination in Prostate Cancer Patients
por: Błaszczuk, Agata, et al.
Publicado: (2023)

Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients
por: Broseta, José Jesús, et al.
Publicado: (2022)

One year of SARS-CoV-2 evolution
por: Wu, Aiping, et al.
Publicado: (2021)

SARS-CoV-2 persistence at subzero temperatures
por: Scarica, Catello, et al.
Publicado: (2021)

Mitigating airborne transmission of SARS-CoV-2
por: Addleman, Sarah, et al.
Publicado: (2021)

SARS‐CoV‐2: March toward adaptation
por: Benedetti, Francesca, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i5vddd5h8ma3rtvpc4r7ai9os7